The largest database of trusted experimental protocols

15 protocols using ficoll hypaque

1

Evaluating Cellular Immunity Against PvGAMA

Check if the same lab product or an alternative is used in the 5 most similar protocols
A lymphocyte proliferation assay (LPA) was carried out to evaluate cellular immunity against PvGAMA. First, PBMCs were isolated from patients who were acutely infected with P. vivax and those who had been in recovery for 8–10 weeks using Ficoll-Hypaque (Stemcell Technologies, Vancouver, Canada). PBMCs were then washed twice with incomplete Roswell Park Memorial Institute (RPMI) 1640 medium. PBMCs were used for the LPA when viability was greater than 90%. PBMCs were suspended in complete RPMI 1640 medium containing 10% fetal bovine serum (FBS), and 2.5  ×  105 PBMCs were added into each well of a 96-well flat-bottomed tissue culture plate (Corning Inc., New York, NY, USA). The cells were then stimulated by 10 μg/mL of purified rPvGAMA or rPvDBPII. The complete RPMI 1640 medium and PBMCs stimulated with 2% v/v of phytohaemagglutinin (PHA) were used as negative and positive controls, respectively. Cells were cultured for 96 h at 37 °C under 5% CO2. After 96 h, the culture supernatant was harvested for cytokine detection.
+ Open protocol
+ Expand
2

Isolation of Monocytes from Human Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human whole blood (WB) was obtained from healthy volunteers as part of a lung cancer metabolism study according to a University of Kentucky IRB approved protocol (IRB# 43807). Monocytes were isolated from WB using the RosetteSep™ human monocyte enrichment cocktail kit (StemCell Technologies Inc., Cambridge). Each mL of WB was mixed and incubated for 20 min with 2 μL of 0.5 mM EDTA, and 50 μL of the RosetteSep™ monocyte negative selection cocktail. The WB was diluted 1:1 with phosphate-buffered saline (PBS) (Ca2+ and Mg2+ free) + 1× antibiotic-antimycotic (Thermo fisher) + 2 % endotoxin-free fetal bovine serum (FBS) and then added to a Ficoll-Hypaque (GE) gradient in SepMate™-50 tubes (StemCell Technologies Inc.), followed by centrifugation at 1,200 ×g for 20 min. The top layers were pooled and then spun for 10 min at 400 ×g. The resulting cell pellets were resuspended in the same 2 % FBS-PBS dilution buffer and washed twice via centrifugation at 600 ×g and 120 ×g for 10 minutes each. Finally, the cells were counted and seeded into 6-well plates at a density of 3 – 5 × 106 cells per well in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 0.2 % glucose, 2 mM glutamine, 10 % FBS, 1× antibiotic-antimycotic, and 50 ng/mL of monocyte colony stimulating factor (M-CSF) (M0 medium).
+ Open protocol
+ Expand
3

Isolation of Naïve CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single‐cell suspensions were obtained from mouse spleens and lymph nodes. Naïve CD4+ T cells were isolated by negative selection (Stemcell Technologies) using biotinylated antibodies directed against non‐CD4+ T cells (CD8, CD11b, CD11c, CD19, CD24, CD25, CD44, CD45R, CD49b, TCRγ/δ, TER119) and streptavidin‐coated magnetic particles.
Fresh peripheral blood mononuclear cells of healthy volunteers were isolated from heparinized blood using Ficoll‐Hypaque density centrifugation, and CD4+ T cells were isolated by negative selection according to the manufacture's protocol (Stemcell Technologies). The human study was approved by the Institutional Review Board (IRB) of Second Xiangya Hospital, Central South University. Informed consent was obtained from each volunteer in accordance with the Declaration of Helsinki. Cells were used at a purity of >95%; 6 samples were evaluated /group.
+ Open protocol
+ Expand
4

Isolation and Characterization of ECFCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the isolation of ECFCs, mononuclear cells (MNCs) were isolated from 16 ml of peripheral blood samples of individual healthy controls and CAD patients using Ficoll-Hypaque density gradient centrifugation (Lymphoprep, STEMCELL TECHNOLOGIES, Vancouver, British Columbia, CA). The isolated MNCs were resuspended in 4 ml of endothelial growth medium-2 (EGM2) with complete supplements (Lonza Ltd, Basel, CH) and seeded onto 2 wells of a 6-well plate coated with fibronectin (Merck Millipore, Burlington, MA, USA). After 2 weeks of cultivation at 37 °C and in 5% CO2, monolayer cells exhibited cobblestone-like morphology were obtained, reseeded and grown to confluence. ECFCs were characterized by flow cytometry (FACS) analysis (see below). All the ECFCs used in this study were cultured within six passages. The study of human specimens of healthy controls and CAD patients has been approved by the Institutional Review Board (IRB#: 1-107-05-155 and 2-108-05-097) of Tri-Service General Hospital. Written informed consent was obtained from all participants. The protocols of this study were consistent with the ethical guidelines of 1975 Helsinki Declaration.
+ Open protocol
+ Expand
5

Isolation of PBMCs and Monocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs and monocytes were isolated from the heparinized venous blood of individuals without DM by dextran sedimentation using Ficoll-Hypaque density gradient centrifugation and Lymphoprep (STEMCELL Technologies, Vancouver, BC, Canada: catalogue number 07851), as previously described60 (link). The cell viability was >98%, as determined by the trypan blue exclusion assay. We isolated monocytes from PBMCs using the plastic adherence method, as previously described60 (link). The resulting cell preparation was confirmed to comprise >85% monocytes by a five-part differential white blood cell analyser. Monocyte morphology was determined by microscopy.
+ Open protocol
+ Expand
6

Pleural Effusion Cytokine Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pleural fluid samples were collected in heparin-treated tubes from each patient using a standard thoracentesis technique within 24 h of hospitalization. Ten milliliters of peripheral blood (PB) was drawn simultaneously. MPE specimens were immediately put on ice and then centrifuged at 1,500 r for 6 min. The cell-free supernatants of MPE and serum were frozen at −80 °C immediately after centrifugation for later determining cytokine concentrations. The MPE cell pellets were resuspended in 1× phosphate buffered saline (PBS), and pleural effusion mononuclear cells (PEMCs) were isolated by Ficoll-Hypaque gradient centrifugation (StemCell Technologies, Vancouver, British Columbia, Canada).
+ Open protocol
+ Expand
7

Cultured AML Samples and Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human AML samples were obtained after receiving informed consents from the patients admitted to the Department of Hematology in Ruijin Hospital. BM leukemic blasts were isolated by Ficoll-Hypaque density gradient centrifugation and cultured with Isocove modified Dulbecco medium (IMDM) supplemented with 10% BIT (Stem Cell Technologies, Vancouver, Canada) for <5 days. Leukemic cell lines (HL-60, Kasumi-1, NB4, NB4-R2, THP-1, U937, K562, and Jurkat) were obtained from Cell Bank of Shanghai Institute of Hematology and cultured in RPMI-1640 medium (Invitrogen Corporation) supplemented with 10% FBS (Gibco-BRL) in 5% CO2 and humidified atmosphere at 37 °C. ATRA was purchased from Sigma-Aldrich.
+ Open protocol
+ Expand
8

HLA-DQ2.5 IFN-γ ELISPOT Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
IFN-γ ELISPOT assays were performed as previously described [3 (link)] (Additional file 3: Materials S2) [18 (link)], except that the assayed PBMCs were isolated by Ficoll/Hypaque (StemCell Technologies) density-gradient centrifugation or by using Cell Preparation Tubes (CPT). Only patients carrying HLA-DQ2.5 were included for this analysis, which was performed in a subsample of 10 CD patients and 11 non-CD subjects.
+ Open protocol
+ Expand
9

Isolation of B Lymphocytes from Peripheral Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells were separated by density-gradient centrifugation on Ficoll-Hypaque, and B lymphocytes were isolated using a B-cell isolation kit according to the manufacturer's instructions (Stem Cell Technologies, Grenoble, France). The purity estimated by flow cytometry using FITC-conjugated anti-CD19 and PE-conjugated anti-CD5 mAbs was over 95%.
+ Open protocol
+ Expand
10

Evaluation of Cellular Immunity against PvMSP1P-19

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heparinized whole blood was diluted in incomplete RPMI 1640 medium at a dilution of 1:1. PBMCs were isolated by overlaying with Ficoll-Hypaque (Stemcell Technologies, Vancouver, CA, USA) and centrifuged at 2,000 rpm, 20°C for 30 min, and then washed twice with incomplete RPMI 1640 medium. The PBMCs were then suspended in complete RPMI 1640 medium containing 10% foetal bovine serum at a density of 3 × 106 cells/mL. PBMC viability >  90% was required for lymphocyte proliferation assay (LPA). LPAs were carried out to evaluate cellular immunity against PvMSP1P-19. Aliquots of 2.5 × 105 cells/well of PBMCs were distributed in triplicate in 96-well flat-bottomed tissue culture plates (Corning Inc., New York, NY, USA) in a volume of 100 μL. The cells were then stimulated by adding 100-μL of 10-μg/mL purified recombinant antigen PvMSP1P-19 or PvDBP region II diluted in incomplete RPMI 1640. The complete RPMI 1640 medium and 2% v/v of PHA were used as negative and positive controls, respectively. Cells were cultured for 96 h at 37°C under 5% CO2. After 48 and 96 h, the culture supernatant was harvested for cytokine detection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!